Keese Kyle 4
4 · Emergent BioSolutions Inc. · Filed Mar 17, 2011
Insider Transaction Report
Form 4
Keese Kyle
SVP, Mfg Ops
Transactions
- Award
Common Stock
2011-03-15+10,598→ 18,759 total - Award
Employee stock option (right to buy)
2011-03-15+21,195→ 21,195 totalExercise: $24.15Exp: 2018-03-14→ Common Stock (21,195 underlying)
Footnotes (3)
- [F1]Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
- [F2]These restricted stock units vest in three equal annual installments beginning on the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.
- [F3]Exercisable in three equal installments on March 14, 2012, March 14, 2013 and March 14, 2015.